|
Scientific Staff
|
| • |
William Ricketts, Ph.D., Vice President and Chief Scientific Officer
|
| • |
Mai Gu, M.D., Ph.D., Medical Director
|
| • |
Hun Kim, M.D., Clinical Pathologist
|
| • |
Khalil Sheibani, M.D., Pathologist
|
| • |
Hannah Mamuszka, MS, Director of Scientific & Pharmaceutical Alliances
|
| • |
David Smith, Ph.D., Principal Research Scientist, R&D Division
|
| • |
Ricardo Parker, Ph.D., Clinical Research Associate
|
| • |
Christine Wheeler, M.D., Pathologist
|
 |
15501 Red Hill Avenue
Tustin, CA 92780
Phone: (800) 576-6326
Fax: (714) 566-0421
Client Services
Phone: (800) 662-6832
Fax: (714) 566-0423
|
|
|
Experts in the Field of Cancer Testing
Dedicated to Improving the Future for Cancer Patients
William Ricketts, Ph.D., Vice President and Chief Scientific Officer
William Ricketts, Ph.D. is the Vice President and Chief Scientific Officer and is responsible for research, new product validation, pharmaceutical alliances and the continued development of molecular technology strategies. Dr. Ricketts received his Ph.D. from the University of California, San Diego and a B.A. in Biology from the University of Virginia. Prior to joining Oncotech Dr. Ricketts worked at Valeant Pharmaceuticals identifying and characterizing novel therapeutics for treating cancer as the project manager for a small molecule kinase inhibitor discovery program. In this role, he was involved in assay development, drug screening, SAR studies, PK studies, clinical trial development and market analysis for potential indications. Dr. Ricketts has been involved in kinase research for twenty years and has performed and published research on the role of adaptor proteins in signal transduction, kinase biology, cell cycle checkpoint controls, and glutathione metabolism.
|
|
